Global Drug Discovery Informatics Market to Reach US$ 7.8 Billion by 2032, Supported by Significant Expansion in the Pharmaceutical Industry

May 18, 2022 | Healthcare

According to the latest report by IMARC Group, titled “Drug Discovery Informatics Market Report by Workflow (Drug Discovery, Drug Development), Function (Sequence Analysis Platforms, Molecular Modelling, Molecular Docking, Clinical Trial Data Management, and Others), Mode (Outsourced, In-house), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), and Others), and Region 2024-2032," the global drug discovery informatics market reached a value of US$ 3.3 Billion in 2023. Drug discovery informatics (DDI) refer to sophisticated bioinformatic algorithmic solutions that evaluate large volumes of biomechanical data regarding gene expression, drug, and disease. They involve a set of software and hardware-based tools, which assist in protecting databases, discovering drugs for their formulation, docking, interpreting, visualizing, and preparing data. Apart from this, drug discovery informatics aid in generating insights related to the development of several drugs post their experimentation in clinical laboratories and customizing systems for different aspects of data. Consequently, they are extensively used in healthcare institutions, pharmaceuticals, biotechnology organizations, and contract research organizations (CROs) for making clinical decisions, managing trials, and performing pharmacovigilance tasks.

Global Drug Discovery Informatics Market Trends:

The drug discovery informatics market is majorly being driven by the increasing prevalence of various chronic disorders and the growing need for effective medication moieties at affordable prices to treat rare diseases. In line with this, the sudden outbreak of coronavirus disease (COVID-19) infection has prompted governments of several nations to invest in the pharmaceutical industry to perform drug discovery for manufacturing novel vaccines. This, in turn, supplemented the widespread adoption of drug discovery informatics for performing virtual screening of molecules, which is acting as another growth-inducing factor. Additionally, the introduction of in-silico modelling tools and physiologically based pharmacokinetic (PBK) simulator that assists in supporting pediatric dose selection for small molecule drugs and forecasting pharmacokinetic outcomes are contributing to the market growth. Moreover, the extensive deployment of drug discovery informatics in the healthcare sector for managing biological information from multiple sources and analyzing new drug entities is propelling the market growth. Other factors, such as strategic collaborations amongst key players and continuous investments in the research and development (R&D) activities for identifying diverse applications of drug discovery informatics and improving its efficacy, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 7.8 Billion by 2032, growing at a CAGR of 9.7% during 2024-2032.

Market Summary:

  • Based on the workflow, the market has been bifurcated into drug discovery and drug development.
  • On the basis of the function, the market has been segregated into sequence analysis platforms, molecular modelling, molecular docking, clinical trial data management, and others.
  • Based on the mode, the market has been bifurcated into outsourced and in-house.
  • On the basis of the end user, the market has been segmented into pharmaceutical companies, biotechnology companies, contract research organization (CROs), and others.
  • On a regional basis, the market has been categorized into North America (United States, and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. 
  • The competitive landscape of the industry has also been examined, along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Workflow, Function, Mode, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Drug Discovery Informatics Market to Reach US$ 7.8 Billion by 2032, Supported by Significant Expansion in the Pharmaceutical Industry
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More